The cost of Reclast infusions can vary significantly based on several factors, including insurance coverage, geographic location, and the specific healthcare provider administering the treatment [1]. While specific price points are not publicly available, general estimates suggest that a single Reclast infusion can range from several hundred to over a thousand dollars [1][2]. This cost typically includes the medication itself and the administration fee for the infusion [1].
What does Reclast treat?
Reclast (zoledronic acid) is primarily used to treat osteoporosis in postmenopausal women and to prevent fractures in men and women with osteoporosis [3]. It is also used to treat Paget's disease of bone and to increase bone mass in men with osteoporosis. Additionally, Reclast is administered to patients following certain surgeries to prevent fractures, and in combination with calcium and vitamin D, to treat hypercalcemia of malignancy [3].
How does Reclast work?
Reclast is a bisphosphonate medication that works by slowing down bone loss [4]. It inhibits osteoclast activity, which are the cells responsible for breaking down bone tissue. By reducing bone resorption, Reclast helps to maintain bone density and strength, thereby reducing the risk of fractures [4].
What are the potential side effects of Reclast infusions?
Common side effects associated with Reclast infusions can include flu-like symptoms, fever, fatigue, dizziness, nausea, vomiting, and pain in the muscles, bones, or joints [3][5]. More serious, though less common, side effects can include osteonecrosis of the jaw (ONJ), a condition characterized by damage to the jawbone, and atypical femur fractures, which are breaks in the thigh bone that can occur with minimal or no trauma [3][5]. Kidney problems can also occur, particularly in individuals with pre-existing kidney issues [5].
How often are Reclast infusions given?
The frequency of Reclast infusions depends on the condition being treated [3]. For osteoporosis, it is typically administered once every two years [3]. For Paget's disease, it is given as a single infusion, and further doses may be considered after at least one year if needed [3]. For hypercalcemia of malignancy, it is usually given as a single infusion [3].
What is the patent status for Reclast?
Drug patent information for Reclast can be complex and is subject to change. Companies often seek patent extensions or file new patents for different formulations or uses. For detailed and up-to-date information on Reclast's patent status, including expiry dates and any ongoing litigation, DrugPatentWatch.com is a valuable resource [6].
Are there alternative treatments for osteoporosis?
Yes, there are alternative treatments for osteoporosis besides Reclast. These include other bisphosphonates administered orally (such as alendronate, risedronate, and ibandronate), hormone replacement therapy, selective estrogen receptor modulators (SERMs), and newer medications like denosumab and teriparatide [7]. The choice of treatment depends on individual patient factors, including the severity of bone loss, risk of fracture, and tolerance for different medications [7].